4.46
[1]. A Perico, et al. Biological monitoring of occupational exposure to cyclohexane by urinary 1,- and 1,4-cyclohexanediol determination. Int Arch Occup Environ Health. 1999 Mar;7():115-.
[]. Bapurao Surnar, et al. Core-shell polymer nanoparticles for prevention of GSH drug detoxification and cisplatin delivery to breast cancer cells. Nanoscale. 15 Nov 14;7(4):17964-79.
[3]. G A Mills, et al. Urinary excretion of cyclohexanediol, a metabolite of the solvent cyclohexanone, by infants in a special care unit. Clin Chem. 199 Jun;36(6):87-4.
[4]. J Mráz, et al. 1,- and 1,4-Cyclohexanediol: major urinary metabolites and biomarkers of exposure to cyclohexane, cyclohexanone, and cyclohexanol in humans. Int Arch Occup Environ Health. 1998 Nov;71(8):56-5.
[5]. Jun Wu, et al. A gene linB responsible for the conversion of beta-HCH and ,3,4,5,6-pentachlorocyclohexanol in Sphingomonas sp. BHC-A. Appl Microbiol Biotechnol. 7 Jan;73(5):197-15.
H3-H319-H335
P61-P64-P71-P8
GHS7